59928 Federal Register / Vol. 88, No. 167 / Wednesday, August 30, 2023 / Notices 

campaign. Do not submit comments by 

email. ATSDR does not accept 

comments by email. 

Donata Green, 

Acting Associate Director, Office of Policy, 

Planning and Partnerships, Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2023–18730 Filed 8–29–23; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–N–1053] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Customer/Partner 

Service Satisfaction Surveys 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing that a proposed collection 

of information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Submit written comments 

(including recommendations) on the 

collection of information by September 

29, 2023. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be submitted to https://

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. The OMB 

control number for this information 

collection is 0910–0360. Also include 

the FDA docket number found in 

brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

JonnaLynn Capezzuto, Office of 

Operations, Food and Drug 

Administration, Three White Flint 

North, 10A–12M, 11601 Landsdown St., 

North Bethesda, MD 20852, 301–796– 

3794, PRAStaff@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Customer/Partner Service Satisfaction 

Surveys 

OMB Control Number 0910–0360— 

Extension 

Under section 1003 of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393), FDA is authorized to conduct 

research and public information 

programs about regulated products and 

responsibilities of the Agency. 

Executive Order 12862, entitled ‘‘Setting 

Customer Service Standard,’’ directs 

Federal Agencies that ‘‘provide 

significant services directly to the 

public’’ to ‘‘survey customers to 

determine the kind and quality of 

services they want and their level of 

satisfaction with existing services.’’ FDA 

is seeking to extend OMB approval to 

conduct customer service satisfaction 

surveys to implement Executive Order 

12862. Participation in the surveys is 

voluntary. This request covers 

customer/partner (including State and 

local governments) service satisfaction 

surveys of regulated entities, such as 

food processors; cosmetic, drug, 

biologic, and medical device 

manufacturers; animal drugs, animal 

food and feed; tobacco products; and 

consumers and health professionals. 

FDA will use the information from 

these surveys to identify strengths and 

weaknesses in service to customers/ 

partners and to make improvements. 

The surveys will measure timeliness, 

appropriateness, clarity, and accuracy of 

information, courtesy, and problem 

resolution in the context of individual 

programs. 

FDA estimates conducting 

approximately 20 customer/partner 

service satisfaction surveys per year, 

each requiring an average of 25 minutes 

for review and completion. We estimate 

respondents to these surveys to be 

between 100 and 20,000 customers/ 

partners. Some of these surveys will be 

repeats of earlier surveys for purposes of 

monitoring customer/partner service 

and developing long-term data. 

Respondents to this collection of 

information cover a broad range of 

stakeholders who have experience with 

certain products regulated by or services 

provided by FDA. 

In the Federal Register of April 25, 

2023 (88 FR 24992), FDA published a 

60-day notice requesting public 

comment on the proposed collection of 

information. One comment was received 

in support of this information 

collection. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

Activity Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average burden per 

response Total hours 

Mail, telephone, web-based survey ................ 85,000 1 85,000 0.42 (25 minutes) ............... 35,700 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Since the last OMB approval of this 

information collection request, FDA 

submitted three requests to increase the 

total burden hours. Therefore, this 

request for extension of OMB approval 

adjusts the number of respondents by an 

increase of 30,000 and the total burden 

hours by an increase of 21,950. 

Dated: August 24, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–18635 Filed 8–29–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the National Advisory 

Council on Migrant Health 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the National 

Advisory Council on Migrant Health 

(NACMH) has scheduled a public 

meeting. Information about NACMH 

and the agenda for this meeting can be 

found on NACMH’s website at https:// 

www.hrsa.gov/advisory-committees/ 

migrant-health. 

DATES: November 1–2, 2023, 9:00 a.m.– 

5:00 p.m. Eastern Standard Time. 

ADDRESSES: This meeting will be held 

in-person at 5600 Fishers Lane, 


lotter on DSK11XQN23PROD with NOTICES1